Two Types of Lacunar Infarcts: Further Arguments From a Study on Prognosis
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background and Purpose — Earlier, we found that lacunar stroke patients with ≥1 asymptomatic lacunar infarcts on CT had leukoaraiosis and hypertension significantly more often than patients without such lesions, and we hypothesized that 2 types of small-vessel disease could be distinguished during life: arteriolosclerosis and microatheromatosis, respectively. Differences in prognosis might sustain this hypothesis of 2 lacunar stroke entities. Therefore, we performed a follow-up in 333 patients with first lacunar stroke, distinguishing those with ≥1 asymptomatic lacunar lesions (LACI+) from those without such lesions (LACI−). Methods — Cross-sectional follow-up was performed after 785±479 days (mean±SD) in 104 LACI+ patients and 865±545 days in 229 LACI− patients. Results — Mortality at the end of follow-up was 33% in LACI+ and 21% in LACI− patients [odds ratio (OR), 1.74; 95% confidence interval (CI), 1.01 to 3.01]. Stroke recurrence rate was 21% in LACI+ and 11% in LACI− (OR, 2.09; 95% CI, 1.08 to 4.06). Forty percent of LACI+ and 26% of LACI− patients had unfavorable outcome at the end of follow-up (OR, 1.95; 95% CI, 1.17 to 3.26). Kaplan-Meier curves showed less favorable survival in LACI+ (log-rank test, P =0.0218) and survival free of stroke (log-rank test, P =0.0121) than in LACI−. When we restricted the analysis to patients with both silent lesions and leukoaraiosis (n=63) compared with those without (n=196), differences were even more pronounced. Conclusions — Prognosis for mortality, recurrent stroke, and overall functional outcome in lacunar stroke patients with ≥1 silent lacunar lesions is more unfavorable than in patients without such lesions. These findings sustain the idea of 2 lacunar stroke entities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Capsular Infarcts: The Underlying Vascular Lesions
Fisher, C. M. (1979) · Archives of Neurology · doi:10.1001/archneur.1979.00500380035003 · Cited by 439
MRI white matter hyperintensities: Three-year follow-up of the Austrian Stroke Prevention Study
Schmidt, R., Fazekas, F., Kapeller, P., Schmidt, H., & Hartung, H.-P. (1999) · Neurology · doi:10.1212/wnl.53.1.132 · Cited by 342
Nonhypertensive Cerebral Small-Vessel Disease: An Autopsy Study
Lammie, G. A., Brannan, F., Slattery, J., & Warlow, C. (1997) · Stroke · doi:10.1161/01.str.28.11.2222 · Cited by 212 · cited 1×
“Rankin score, 4 or 5 (n 70 and 159, respectively) 8 (11) 9 (5) 2.”
Research works printed but not linked: 31
- 10.1093/brain/114.2.761 · DOI · Paper page
- 10.1002/ana.410300612 · DOI · Paper page
- 10.1161/str.24.5.8488519 · doi:10.1161/str.24.5.8488519
- 10.1161/str.28.11.2222 · doi:10.1161/str.28.11.2222
- 10.1161/str.26.1.30 · doi:10.1161/str.26.1.30
- 10.1159/000015841 · DOI
- 10.1161/str.30.11.2296 · doi:10.1161/str.30.11.2296
- 10.2302/kjm.49.supplement1_A117 · doi:10.2302/kjm.49.supplement1_a117
- 10.1161/str.28.7.1458 · doi:10.1161/str.28.7.1458
- 10.1017/S0317167100033527 · doi:10.1017/s0317167100033527
- 10.1016/S0022-510X(98)00182-8 · DOI
- 10.1161/str.30.2.378 · doi:10.1161/str.30.2.378
- 10.1001/archneur.1996.00550070088015 · DOI · Paper page
- 10.1111/j.1600-0404.1995.tb07028.x · DOI
- 10.1161/str.30.10.2053 · doi:10.1161/str.30.10.2053
- 10.1161/str.27.4.661 · doi:10.1161/str.27.4.661
- 10.1161/str.21.6.2349592 · doi:10.1161/str.21.6.2349592
- 10.1161/str.18.3.3590244 · doi:10.1161/str.18.3.3590244
- 10.1161/str.25.12.7974577 · doi:10.1161/str.25.12.7974577
- 10.1161/str.26.11.2027 · doi:10.1161/str.26.11.2027
- 10.1136/jnnp.53.10.824 · DOI · Paper page
- 10.1007/s004150170200 · DOI
- 10.1001/archneur.1996.00550030077025 · DOI
- 10.1159/000015810 · DOI
- 10.1161/str.21.10.2219206 · doi:10.1161/str.21.10.2219206
- 10.1161/str.27.5.842 · doi:10.1161/str.27.5.842
- 10.1093/brain/117.4.825 · DOI · Paper page
- 10.1097/00004872-199816100-00005 · DOI
- 10.1161/str.29.3.570 · doi:10.1161/str.29.3.570
- 10.1001/archneur.57.8.1139 · DOI
- 10.1001/archneur.58.4.577 · DOI · Paper page
Cited by
Pantoni, L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70104-6 · Cited by 3,405
Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging
Wardlaw, J. M., Smith, C., & Dichgans, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70060-7 · Cited by 1,657
Update on cerebral small vessel disease: a dynamic whole-brain disease
Shi, Y., & Wardlaw, J. M. (2016) · Stroke and Vascular Neurology · doi:10.1136/svn-2016-000035 · Cited by 459
Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction
Hassan, A. (2004) · Brain · doi:10.1093/brain/awh023 · Cited by 338
Treatment of Warfarin-Associated Intracerebral Hemorrhage: Literature Review and Expert Opinion
Aguilar, M. I., Hart, R. G., Kase, C. S., Freeman, W. D., Hoeben, B. J., García, R. C., Ansell, J. E., Mayer, S. A., Norrving, B., Rosand, J., et al. (2007) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)60970-1 · Cited by 306
Metadata
- Authors
- de Jong, G., Kessels, F., & Lodder, J.
- Venue
- Stroke
- Published
- 2002-08
- Volume
- 33
- Issue
- 8
- Pages
- 2072-2076
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2041472662
- Cited by
- 125
- References
- 3
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Two Types of Lacunar Infarcts: Further Arguments From a Study on Prognosis. https://app.cochat.ai/papers/10.1161/01.str.0000022807.06923.a3
- The paper
- de Jong, G., Kessels, F., & Lodder, J. (2002). Two Types of Lacunar Infarcts: Further Arguments From a Study on Prognosis. Stroke. https://doi.org/10.1161/01.str.0000022807.06923.a3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.